> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 48 New, Revised PSGs Out
- URL: https://www.fdaweb.com/48-new-revised-psgs-out/
- Published: 2025-05-20T12:00:00.000Z
- Updated: 2026-09-14T15:12:21.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5159209

FDA has published 34 new and 14 revised product-specific guidances (PSGs) with recommendations for developing generic drugs and generating evidence to support ANDAs. The agency says the latest batch of [PSGs](https://www.accessdata.fda.gov/scripts/cder/psg/index.cfm?utm%5Fmedium=email&utm%5Fsource=govdelivery) contains:

- 37 PSGs for products with no approved ANDAs, including six complex products;
- 13 PSGs for complex products (10 new and three revised);
- PSGs for products used to treat postpartum depression, Duchenne muscular dystrophy, and other conditions; and
- additional noteworthy PSGs, including those supported by GDUFA-funded research with reference-listed products used to treat conditions such as bronchoconstriction, asthma, chronic obstructive pulmonary disease, allergic reactions, and other conditions.

FDA also updated its PSG Web page (linked above).